Purpose Unlimited’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.2M Buy
63,177
+47,674
+308% +$7.95M 0.36% 53
2026
Q2
$2.98M Buy
15,503
+1,264
+9% +$238K 0.11% 83
2026
Q1
$2.81M Sell
14,239
-22,506
-61% -$4.34M 0.12% 92
2025
Q4
$6.76M Buy
+36,745
New +$6.44M 0.31% 60

Other funds holding AZN

Purpose Unlimited's AZN Position: Q3 2026 in Review

Purpose Unlimited increased its AstraZeneca (AZN) stake by 308% in Q3 2026, buying an estimated $7.95M and bringing the position to 63,177 shares worth $10.2M. The position accounts for 0.36% of the portfolio, ranked #53.

Purpose Unlimited first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. 1,444 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Purpose Unlimited held 63,177 shares of AstraZeneca worth $10.2M as of Q3 2026.
  • Purpose Unlimited bought 47,674 AstraZeneca shares in Q3 2026, an estimated $7.95M.
  • AstraZeneca made up 0.36% of Purpose Unlimited's portfolio in Q3 2026, its #53 holding.
  • Purpose Unlimited first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • 1,444 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Purpose Unlimited's 13F filing for Q3 2026, filed 12 Nov 2026.